Literature DB >> 28666219

Lipid-induced endoplasmic reticulum stress in X-linked adrenoleukodystrophy.

Malu-Clair van de Beek1, Rob Ofman1, Inge Dijkstra1, Frits Wijburg2, Marc Engelen2, Ronald Wanders3, Stephan Kemp4.   

Abstract

X-linked adrenoleukodystrophy (ALD) is a progressive neurodegenerative disease that is caused by mutations in the ABCD1 gene and characterized by elevated levels of very long-chain fatty acids (VLCFA) in plasma and tissues, with the most pronounced increase in the central nervous system. Virtually all male patients develop adrenal insufficiency and myelopathy (adrenomyeloneuropathy), but a subset develops a fatal cerebral demyelinating disease (known as cerebral ALD). Female patients may also develop myelopathy, but adrenal insufficiency or leukodystrophy are very rare. ALD has been associated with mitochondrial dysfunction, oxidative stress and bioenergetic failure, but the mechanism by which VLCFA accumulation triggers these effects has not been resolved thus far. In this study, we used primary human fibroblasts from normal subjects and ALD patients to investigate whether VLCFA can induce endoplasmic reticulum stress. We show that saturated VLCFA (C26:0) induce endoplasmic reticulum stress in fibroblasts from ALD patients, but not in controls. Furthermore, there is a clear correlation between the chain-length of the fatty acid and the induction of endoplasmic reticulum stress. Exposure of ALD fibroblasts to C26:0, resulted in increased expression of additional endoplasmic reticulum stress markers (EDEM1, GADD34 and CHOP) and in lipoapoptosis. This new insight into the underlying mechanism of VLCFA-induced toxicity is of great importance for the development of a disease modifying treatment for ALD aimed at the normalization of VLCFA levels in tissues.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adrenoleukodystrophy; Endoplasmic reticulum stress; Fatty acids; Lipotoxicity; Neurodegeneration

Mesh:

Substances:

Year:  2017        PMID: 28666219     DOI: 10.1016/j.bbadis.2017.06.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  18 in total

1.  ER-stress mobilization of death-associated protein kinase-1-dependent xenophagy counteracts mitochondria stress-induced epithelial barrier dysfunction.

Authors:  Fernando Lopes; Åsa V Keita; Alpana Saxena; Jose Luis Reyes; Nicole L Mancini; Ala Al Rajabi; Arthur Wang; Cristiane H Baggio; Michael Dicay; Rob van Dalen; Younghee Ahn; Matheus B H Carneiro; Nathan C Peters; Jong M Rho; Wallace K MacNaughton; Stephen E Girardin; Humberto Jijon; Dana J Philpott; Johan D Söderholm; Derek M McKay
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

2.  Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy.

Authors:  Bela R Turk; Christina L Nemeth; Joel S Marx; Carol Tiffany; Richard Jones; Benjamin Theisen; Siva Kambhampati; Raj Ramireddy; Sarabdeep Singh; Melissa Rosen; Miriam L Kaufman; Connor F Murray; Paul A Watkins; Sujatha Kannan; Rangaramanujam Kannan; Ali Fatemi
Journal:  Ann Neurol       Date:  2018-09       Impact factor: 10.422

3.  Restless Legs Syndrome in X-linked adrenoleukodystrophy.

Authors:  John W Winkelman; Natalie R Grant; Francine Molay; Christopher D Stephen; Reza Sadjadi; Florian S Eichler
Journal:  Sleep Med       Date:  2022-02-16       Impact factor: 4.842

4.  Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy.

Authors:  Quentin Raas; Malu-Clair van de Beek; Sonja Forss-Petter; Inge Me Dijkstra; Abigail Deschiffart; Briana C Freshner; Tamara J Stevenson; Yorrick Rj Jaspers; Liselotte Nagtzaam; Ronald Ja Wanders; Michel van Weeghel; Joo-Yeon Engelen-Lee; Marc Engelen; Florian Eichler; Johannes Berger; Joshua L Bonkowsky; Stephan Kemp
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

5.  Oxidative Imbalance, Nitrative Stress, and Inflammation in C6 Glial Cells Exposed to Hexacosanoic Acid: Protective Effect of N-acetyl-L-cysteine, Trolox, and Rosuvastatin.

Authors:  Desirèe Padilha Marchetti; Luiza Steffens; Carlos E Jacques; Gilian B Guerreiro; Caroline P Mescka; Marion Deon; Daniella M de Coelho; Dinara J Moura; Alice G Viario; Fernanda Poletto; Adriana S Coitinho; Laura B Jardim; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2018-10-09       Impact factor: 5.046

6.  Drug discovery for X-linked adrenoleukodystrophy: An unbiased screen for compounds that lower very long-chain fatty acids.

Authors:  Ann B Moser; Yanqiu Liu; Xiaohai Shi; Ulrike Schrifl; Shandi Hiebler; Ali Fatemi; Nancy E Braverman; Steven J Steinberg; Paul A Watkins
Journal:  J Cell Biochem       Date:  2021-05-30       Impact factor: 4.480

7.  An UPLC-MS/MS Assay to Measure Glutathione as Marker for Oxidative Stress in Cultured Cells.

Authors:  Katharina Herzog; Lodewijk IJlst; Arno G van Cruchten; Carlo W T van Roermund; Wim Kulik; Ronald J A Wanders; Hans R Waterham
Journal:  Metabolites       Date:  2019-03-05

Review 8.  X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies.

Authors:  Bela R Turk; Christiane Theda; Ali Fatemi; Ann B Moser
Journal:  Int J Dev Neurosci       Date:  2020-01-26       Impact factor: 2.457

9.  Modeling and rescue of defective blood-brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients.

Authors:  Catherine A A Lee; Hannah S Seo; Anibal G Armien; Frank S Bates; Jakub Tolar; Samira M Azarin
Journal:  Fluids Barriers CNS       Date:  2018-04-04

10.  Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.

Authors:  Pablo Ranea-Robles; Nathalie Launay; Montserrat Ruiz; Noel Ylagan Calingasan; Magali Dumont; Alba Naudí; Manuel Portero-Otín; Reinald Pamplona; Isidre Ferrer; M Flint Beal; Stéphane Fourcade; Aurora Pujol
Journal:  EMBO Mol Med       Date:  2018-08       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.